Figure 1: How has your prescribing of ezetimibe changed over time? 

This is a stacked bar graph which shows the number of prescriptions of ezetimibe and ezetimibe + statin FDC that this GP wrote, as a rate per 1000 Medicare consultations. Number of prescriptions per 1000 Medicare consultations is shown on the y-axis, and ranges from 0 to 60, increasing in 10 unit increments. The calendar years 2014, 2015 and 2016 are shown on the x axis.

Three stacked bars are shown to reflect ezetimibe prescribing over the calendar years 2014, 2015 and 2016. On each of these individual bars, the bottom stack represents prescriptions of ezetimibe per 1000 Medicare consultations and the top stack represents prescriptions of ezetimibe + statin FDC per 1000 Medicare consultations.

Beginning at the leftmost bar in the graph:

  • The first stacked bar represents data for calendar year 2014. In 2014 this GP wrote 24 prescriptions for ezetimibe and 4 prescriptions for ezetimibe + statin FDC per 1000 Medicare consultations.
  • The second stacked bar represents data for calendar year 2015. In 2015 this GP wrote 22 prescriptions for ezetimibe and 11 prescriptions for ezetimibe + statin FDC per 1000 Medicare consultations.
  • The third stacked bar represents data for calendar year 2016. In 2016 this GP wrote 22 prescriptions for ezetimibe and 20 prescriptions for ezetimibe + statin FDC per 1000 Medicare consultations.

Return to the Practice Review – Managing lipids: Statins revisited page

Figure 2: How adherent are your patients to statin treatment? 

This table shows this GP's total number of patients who had statin monotherapy dispensed in 2016 and how many prescriptions they had dispensed. Number of statin prescriptions dispensed is stratified into four columns: 1-3, 4-6, 7-9 and ≥ 10. In each of these columns, the number of patients who had statin prescriptions dispensed is also expressed as a percentage.

The data is also compared to the average of GPs in the same RA. That is, the total number of patients who had 1-3, 4-6, 7-9, ≥ 10 statin prescriptions dispensed in 2016 is expressed as a percentage.

A reference to the expected requirements of a patient on statin monotherapy is provided. As each pack of statins consists of 28-30 tablets, at the usual daily dose of a statin, it is expected that a patient would require ≥ 10 prescriptions per year.

In 2016, this GP had 128 patients taking statin monotherapy. Of these:

  • 17 (13%) patients had 1-3 prescriptions dispensed
  • 19 (15%) patients had 4-6 prescriptions dispensed
  • 21 (16%) patients had 7-9 prescriptions dispensed
  • 71 (55%) patients had ≥ 10 prescriptions dispensed

In 2016, of all patients in this GP's RA,

  • 28% of patients had 1-3 prescriptions dispensed
  • 27% of patients had 4-6 prescriptions dispensed
  • 14% of patients had 7-9 prescriptions dispensed
  • 31% of patients had ≥ 10 prescriptions dispensed

Return to the Practice Review – Managing lipids: Statins revisited page

Figure 3: What intensity of statin treatment do you prescribe?

Two pie graphs are shown here side by side. The graphs show a breakdown of statin treatment used in practice in 2016 according to the intensity of statin prescribed. On the left is the pie graph representing the GP's data and on the right is the pie graph representing the RA data.

A reference to the different statin intensity treatment is provided.

  • Low-intensity statin consists of: simvastatin 5 mg, 10 mg, pravastatin 10 mg, 20 mg;
  • Moderate-intensity statin consists of: atorvastatin 10 mg, 20 mg, rosuvastatin 5 mg, 10 mg, simvastatin 20 mg, 40 mg, 80 mg, pravastatin 40 mg, 80 mg, fluvastatin 80 mg
  • High-intensity statin consists of: atorvastatin 40 mg, 80 mg, rosuvastatin 20 mg, 40 mg.

Left pie graph - You (GP) data

In 2016 this GP had:

  • 17 (13%) of patients using low-intensity statin
  • 72 (55%) of patients using moderate-intensity statin
  • 42 (32%) of patients using high-intensity statin

Right pie graph – RA data

In 2016 for all patients in the RA:

  • 3% of patients were using low-intensity statin
  • 61% of patients were using moderate-intensity statin
  • 36% of patients were using high-intensity statin

Return to the Practice Review – Managing lipids: Statins revisited page

Figure 4: How many of your patients started ezetimibe due to a clinically important adverse event with a statin?

This table shows how many patients received ezetimibe following a clinically important adverse event with a statin in 2014, 2015 and 2016 for the GP receiving the feedback. Patient numbers are also expressed as a percentage of all patients using ezetimibe treatment.

RA data is also provided for comparison. Here, the total number of patients who were supplied ezetimibe due to a clinically important adverse event with a statin, is expressed as percentage of all patients using ezetimibe treatment in the GP's RA in 2014, 2015 and 2016.

This GP supplied ezetimibe to

  • 7 (35%) of patients following a clinically important adverse event with statin in 2014
  • 6 (29%) of patients following a clinically important adverse event with statin in 2015
  • 10 (42%) of patients following a clinically important adverse event with statin in 2016

For all patients in the RA, ezetimibe was supplied to

  • 9% of patients following a clinically important adverse event with statin in 2014
  • 8% of patients following a clinically important adverse event with statin in 2015
  • 6% of patients following a clinically important adverse event with statin in 2016

Return to the Practice Review – Managing lipids: Statins revisited page

Figure 5: Age profile of patients in your practice

This graph shows the age profile of this GP's patients represented by a black line, as well as the shaded area between the 25th and 75th percentiles for the RA. Patient age in years is displayed on the x axis and is stratified into: 0-14, 15-29, 30-44, 45-59, 60-74, 75-89 and 90+. Number of patients is shown on the y axis. The range shown is 0–800, increasing in 200 increments.

For in the time period 1 January 2016 to 31 December 2016, this GP had:

  • 226 patients aged 0-14 years. The 25th percentile in the RA is 116 patients and the 75th percentile in the RA is 503 patients
  • 131 patients aged 15-29 years. The 25th percentile in the RA is 122 patients and the 75th percentile in the RA is 489 patients
  • 189 patients aged 30-44 years. The 25th percentile in the RA is 157 patients and the 75th percentile in the RA is 559 patients
  • 202 patients aged 45-59 years. The 25th percentile in the RA is 168 patients and the 75th percentile in the RA is 444 patients
  • 197 of patients aged 60-74 years. The 25th percentile in the RA is 122 patients and the 75th percentile in the RA is 323 patients
  • 78 number of patients aged 75-89 years. The 25th percentile in the RA is 41 patients and the 75th percentile in the RA is 146 patients
  • 12 patients aged 90+. The 25th percentile in the RA is 2 patients and the 75th percentile in the RA is 13 patients

Return to the Practice Review – Managing lipids: Statins revisited page

Figure 6: Your Medicare patients and concession card holders

This table shows the total number of unique patients that the GP has seen between 1 April 2016 and 30 June 2016. The median for each RA is also provided. Number of patients is stratified into:

  • patients who received a Medicare Category 1 benefit and
  • patients who had a prescription written for them by this GP, who then had this prescription dispensed using a concession card (or safety net card).

Between 1 April 2016 and 30 June 2016, This GP had

  • 631 patients who received a Medicare Category 1 benefit
  • 164 patients who had a prescription dispensed using a concession or safety net card.

Between 1 April 2016 and 30 June 2016 in this RA,

  • The median number of patients who received a Medicare Category 1 benefit is 644.
  • The median number of patients who had a prescription dispensed using a concession or safety net card is 66.

Return to the Practice Review – Managing lipids: Statins revisited page